Highlights
NASDAQ: VTVT       Vtv Theraptcs Cl A
Last Price Today's Change   Day's Range   Trading Volume
1.525   +0.025 (1.67%)  1.50 - 1.50  9,580

Overview

 
Avg Volume (4 weeks):119,863
4 Weeks Range:1.45 - 1.67
4 Weeks Price Volatility (%):
34.09%
52 Weeks Range:1.00 - 3.50
52 Weeks Price Volatility (%):
21.00%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

vTv Therapeutics Inc operates in the United States healthcare sector. Its key business includes the development of orally administered small molecule drug candidates for the treatment of neurological disorders such as the Alzheimer's disease. Its major drug candidate to treat Alzheimer's is azeliragon (TTP488), an orally administered drug. Its other products include TTP399, type II diabetes drug candidate. TTP399 is also an orally administered drug that targets the glucagon-like peptide-1 receptor. It also has over three additional programs in various stages of clinical development for the prevention of muscle weakness and the treatment of inflammatory disorders.

  Be the first to like this.
 


 

2484  2041  430  4012 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 BBT 54.24+0.75 
 CBS 40.77+1.43 
 STI 70.13+0.87 
 DEST 0.11-0.05 
 GHDX 63.440.00 
 UBNK 14.12-0.41 
 DFFN 0.595+0.162 
Partners & Brokers